259 related articles for article (PubMed ID: 6579963)
21. Hyperlipoproteinemia, atherosclerosis and gemfibrozil.
Nash DT
Angiology; 1982 Sep; 33(9):594-602. PubMed ID: 6957155
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
[TBL] [Abstract][Full Text] [Related]
23. Fibric acids: effects on lipids and lipoprotein metabolism.
Grundy SM; Vega GL
Am J Med; 1987 Nov; 83(5B):9-20. PubMed ID: 3318457
[TBL] [Abstract][Full Text] [Related]
24. Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats.
Okada K; Yagasaki K; Mochizuki T; Takagi K; Irikura T
Biochem Pharmacol; 1985 Sep; 34(18):3361-7. PubMed ID: 4038342
[TBL] [Abstract][Full Text] [Related]
25. Nutritional & pharmacologic management of hyperlipoproteinemia.
Pickering JE
Angiology; 1982 Sep; 33(9):577-80. PubMed ID: 6957154
[TBL] [Abstract][Full Text] [Related]
26. Effects of plasma cholesterol lowering agents on hepatobiliary lipid metabolism and cholesterol turnover in the rhesus monkey.
Redinger RN; Passi RB
Can J Physiol Pharmacol; 1979 Mar; 57(3):235-41. PubMed ID: 109175
[TBL] [Abstract][Full Text] [Related]
27. Effect of simvastatin (MK-733) on sterol and bile acid excretion in rabbits.
Ishida F; Iizuka Y; Kakubari K; Kurahashi Y; Sawasaki Y; Kamei T
Jpn J Pharmacol; 1990 May; 53(1):35-45. PubMed ID: 2352377
[TBL] [Abstract][Full Text] [Related]
28. Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.
Heller F; Harvengt C
Eur J Clin Pharmacol; 1983; 25(1):57-63. PubMed ID: 6617725
[TBL] [Abstract][Full Text] [Related]
29. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
30. Rapid modulation of lipogenesis by clofibrate in rat and monkey hepatocytes.
Capuzzi DM; Lackman RD; Alexander J; Intenzo CM; Reed MA
Biochim Biophys Acta; 1975 Oct; 409(1):144-55. PubMed ID: 810176
[TBL] [Abstract][Full Text] [Related]
31. Additive hypocholesterolemic effect of psyllium and cholestyramine in the hamster: influence on fecal sterol and bile acid profiles.
Daggy BP; O'Connell NC; Jerdack GR; Stinson BA; Setchell KD
J Lipid Res; 1997 Mar; 38(3):491-502. PubMed ID: 9101430
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol absorption in man: effect of administration of clofibrate and/or cholestyramine.
McNamara DJ; Davidson NO; Samuel P; Ahrens EH
J Lipid Res; 1980 Nov; 21(8):1058-64. PubMed ID: 7462801
[TBL] [Abstract][Full Text] [Related]
33. Effects of N-(4-methylbenzylthiocarbonyl)-L-phenylalanine (KF 1492), a new phenylalanine derivative on lipid synthesis in vivo, inhibition of hepatic cholesterol synthesis and 3-hydroxy-3-methylglutaryl-Co A reductase.
Ishii A; Deguchi T; Marumo H; Tanaka M
J Pharmacobiodyn; 1981 Dec; 4(12):933-9. PubMed ID: 7341749
[TBL] [Abstract][Full Text] [Related]
34. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
Yamamoto A; Matsuzawa Y; Yokoyama S; Funahashi T; Yamamura T; Kishino B
Am J Cardiol; 1986 Jun; 57(16):29H-35H. PubMed ID: 3728307
[TBL] [Abstract][Full Text] [Related]
35. Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate.
Kyrklund C; Backman JT; Kivistö KT; Neuvonen M; Laitila J; Neuvonen PJ
Clin Pharmacol Ther; 2001 May; 69(5):340-5. PubMed ID: 11372002
[TBL] [Abstract][Full Text] [Related]
36. The hypocholesterolemic action of TA-7552 and its effects on cholesterol metabolism in the rat.
Takashima K; Kohno T; Mori T; Ohtani A; Hirakoso K; Takeyama S
Atherosclerosis; 1994 Jun; 107(2):247-57. PubMed ID: 7980699
[TBL] [Abstract][Full Text] [Related]
37. [Study on the effects of the hypocholesteremic agents, cholestyramine and compactin on the induction of renal tumors in rats by N-ethyl-N-hydroxyethyl nitrosamine].
Hashimoto S
Nihon Hinyokika Gakkai Zasshi; 1992 Jan; 83(1):75-84. PubMed ID: 1564828
[TBL] [Abstract][Full Text] [Related]
38. Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine.
Kim DN; Lee KT; Reiner JM; Thomas WA
J Lipid Res; 1974 Jul; 15(4):326-31. PubMed ID: 4854142
[TBL] [Abstract][Full Text] [Related]
39. Studies on hypoxic dyslipidaemia. Effect of lipid modulating drugs.
Mälkönen M; Muona M; Manninen V
Acta Med Scand Suppl; 1982; 668():130-5. PubMed ID: 6963088
[TBL] [Abstract][Full Text] [Related]
40. [Studies on the mechanism of lowering of the cholesterol level by ethyl-alpha-p-chlorophenoxy-isobutyrate (clofibrate) (author's transl)].
Nakamura H
Hokkaido Igaku Zasshi; 1976 Jul; 51(4):289-97. PubMed ID: 1033897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
